Beauty Farm Medical and Health Industry Inc. (Beauty Farm) reported the repurchase of 31,000 ordinary shares on 23 October 2026, according to its filing with the Hong Kong Stock Exchange.
The shares were bought on-market at prices ranging from HKD 16.75 to HKD 16.98, translating into a volume-weighted average cost of HKD 16.8826 and an aggregate consideration of HKD 0.52 million.
Key post-transaction metrics: • Issued shares outstanding (excluding treasury shares) fell by 0.01% to 247.52 million. • Treasury shares increased from 4.04 million to 4.07 million. • Total issued shares remained unchanged at 251.59 million, as the repurchased shares were retained in treasury.
Buyback mandate status: • Shareholders authorised repurchases of up to 24.85 million shares at the 26 June 2026 annual general meeting. • Cumulative repurchases under this mandate have reached 998,500 shares, representing 0.40% of the issued share base when the mandate was approved. • In line with Hong Kong Listing Rules, Beauty Farm is subject to a moratorium on new share issues or treasury share sales until 22 November 2026.
The board confirmed that the repurchase complied with all relevant listing regulations and that funds for the transaction have been duly settled.
Comments